Valproate in the treatment of PTSD: systematic review and meta analysis

References

• Health NCCfM. Post-traumatic stress disorder: the management of PTSD in adults and children in primary and secondary care. In: National clinical practice guideline. Edited by NICE. Gaskell and the British Psychological Society; 2005
   Google Scholar
• Asnis GM, Kohn SR, Henderson M, et al. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs 2004;64:383–404
   PubMed Web of Science ®Google Scholar
• Keck Jr PE, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992;12:36S–41S
   Google Scholar
• Post RM, Weiss SR, Smith M, et al. Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder. Ann NY Acad Sci 1997;821:285–95
   PubMed Web of Science ®Google Scholar
• Adamec R. Transmitter systems involved in neural plasticity underlying increased anxiety and defense – implications for understanding anxiety following traumatic stress. Neurosci Biobehav Rev 1997;21:755–65
   PubMed Web of Science ®Google Scholar
• Nutt DJ, Malizia AL. Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry 2004;65 (Suppl 1):11–7
   PubMed Web of Science ®Google Scholar
• Blair HT, Sotres-Bayon F, Moita MA, et al. The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli. Neuroscience 2005;133:561–9
   PubMed Web of Science ®Google Scholar
• Villarreal G, King CY. Brain imaging in posttraumatic stress disorder. Semin Clin Neuropsychiatry 2001;6:131–45
   PubMedGoogle Scholar
• Vajda FJ. Valproate and neuroprotection. J Clin Neurosci 2002;9:508–14
   PubMed Web of Science ®Google Scholar
• Bowden CL, Singh V. Valproate in bipolar disorder: 2000 onwards. Acta Psychiatr Scand Suppl 2005:13–20
   PubMedGoogle Scholar
• Blake DD, Weathers FW, Nagy LM. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav Ther 1990;13: 187–8
   Google Scholar
• Weiss DS, Marmar CR. The impact of event scale – revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. A handbook for practitioners. New York: Guildford Press; 1996. p. 399–411
   Google Scholar
• Foa EB, Riggs DS, Dancu CV. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress 1993;6:459–73
   Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5
   PubMed Web of Science ®Google Scholar
• Moncrieff J, Churchill R, Drummond D, et al. Development of a quality assessment instrument for trials of treatments for depression and neurosis. Int J Methods Psychiatr Res 2001;10:126–133
   Google Scholar
• Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991;52:361–4
   PubMed Web of Science ®Google Scholar
• Szymanski HV, Olympia J. Divalproex in posttraumatic stress disorder. Am J Psychiatry 1991;148:1086–7
   PubMed Web of Science ®Google Scholar
• Berigan TR, Holzgang A. Valproate as an alternative in post-traumatic stress disorder: a case report. Mil Med 1995;160:318
   PubMed Web of Science ®Google Scholar
• Ford N. The use of anticonvulsants in posttraumatic stress disorder: case study and overview. J Trauma Stress 1996;9: 857–63
   PubMed Web of Science ®Google Scholar
• Clark RD, Canive JM, Calais LA, et al. Divalproex in posttraumatic stress disorder: an open-label clinical trial. J Trauma Stress 1999;12:395–401
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Cloitre M, Whiteside JE, et al. An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuse. Curr Ther Res 2003;64:45–54
   PubMed Web of Science ®Google Scholar
• Petty F, Davis LL, Nugent AL, et al. Valproate therapy for chronic, combat-induced posttraumatic stress disorder. J Clin Psychopharmacol 2002;22:100–1
   PubMed Web of Science ®Google Scholar
• Otte C, Wiedemann K, Yassouridis A, et al. Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study. J Clin Psychopharmacol 2004;24:106–8
   PubMed Web of Science ®Google Scholar
• Looff D, Grimley P, Kuller F, et al. Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry 1995;34:703–4
   PubMed Web of Science ®Google Scholar
• Lipper S. PTSD and carbamazepine. Am J Psychiatry 1988;145:1322–3
   PubMed Web of Science ®Google Scholar
• Berigan T. Oxcarbazepine treatment of posttraumatic stress disorder. Can J Psychiatry 2002;47:973–4
   PubMed Web of Science ®Google Scholar
• Berlant JL. Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry 2001;62 (Suppl 17):60–3
   PubMedGoogle Scholar
• Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 2002;63:15–20
   PubMed Web of Science ®Google Scholar
• Berigan TR. Gabapentin and PTSD. J Clin Psychiatry 2002;63:744
   PubMed Web of Science ®Google Scholar
• Taylor FB. Tiagabine for posttraumatic stress disorder: a case series of 7 women. J Clin Psychiatry 2003;64:1421–5
   PubMed Web of Science ®Google Scholar
• Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048–60
   PubMed Web of Science ®Google Scholar
• Breslau N, Kessler RC, Chilcoat HD, et al. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit area survey of trauma. Arch Gen Psychiatry 1998;55: 626–32
   PubMed Web of Science ®Google Scholar
• Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 2000;48:740–54
   Google Scholar
• Gould E, Tanapat P, Rydel T, et al. Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 2000;48:715–20
   PubMed Web of Science ®Google Scholar
• Hageman I, Andersen HS, Jorgensen MB. Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy. Acta Psychiatr Scand 2001;104:411–22
   Google Scholar
• Fichtner CG, Poddig BE, DeVito RA. Post-traumatic stress disorder: pathophysiological aspects and pharmacological approaches to treatment. CNS Drugs 1997;8:293–322
   Google Scholar
• Leviel V, Naquet R. A study of the action of valproic acid on the kindling effect. Epilepsia 1977;18:229–34
   PubMed Web of Science ®Google Scholar
• Wada JA. Pharmacological prophylaxis in the kindling model of epilepsy. Arch Neurol 1977;34:389–95
   PubMed Web of Science ®Google Scholar
• Davis LL, Bartolucci A, Petty F. Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord 2005;85:259–66
   Google Scholar